Aimmune Therapeutics Inc Institutional ownership
What is the Institutional ownership of Aimmune Therapeutics Inc?
The Institutional ownership of Aimmune Therapeutics Inc is 82.85%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Aimmune Therapeutics Inc
Companies with institutional ownership similar to Aimmune Therapeutics Inc
- VSE has Institutional ownership of 82.75%
- Lakeland has Institutional ownership of 82.76%
- Elementis Plc has Institutional ownership of 82.82%
- Natural Gas Services has Institutional ownership of 82.83%
- Copart has Institutional ownership of 82.84%
- CVC Credit Partners European Opportunities has Institutional ownership of 82.84%
- Aimmune Therapeutics Inc has Institutional ownership of 82.85%
- Sinclair Inc has Institutional ownership of 82.87%
- Zions Bancorporation, National Association has Institutional ownership of 82.87%
- Cboe Global Markets has Institutional ownership of 82.89%
- Ebiquity plc has Institutional ownership of 82.92%
- Schlumberger NV has Institutional ownership of 82.93%
- DISH Network has Institutional ownership of 82.94%